TD Asset Management’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$142M Buy
404,449
+37,202
+10% +$13.3M 0.12% 156
2025
Q4
$120M Sell
367,247
-18,473
-5% -$5.86M 0.1% 176
2025
Q3
$109M Sell
385,720
-20,557
-5% -$5.96M 0.09% 190
2025
Q2
$113M Sell
406,277
-85,696
-17% -$24.3M 0.1% 178
2025
Q1
$153M Sell
491,973
-27,366
-5% -$8.08M 0.14% 145
2024
Q4
$135M Sell
519,339
-43,508
-8% -$12.9M 0.12% 160
2024
Q3
$182M Sell
562,847
-21,699
-4% -$7.1M 0.16% 135
2024
Q2
$183M Buy
584,546
+48,573
+9% +$14.3M 0.17% 129
2024
Q1
$152M Sell
535,973
-26,839
-5% -$7.85M 0.14% 150
2023
Q4
$162M Sell
562,812
-13,577
-2% -$3.7M 0.16% 122
2023
Q3
$155M Buy
576,389
+143,109
+33% +$35.7M 0.19% 103
2023
Q2
$96.2M Sell
433,280
-22,835
-5% -$5.3M 0.11% 149
2023
Q1
$110M Buy
456,115
+4,734
+1% +$1.16M 0.13% 136
2022
Q4
$119M Sell
451,381
-15,966
-3% -$4.28M 0.15% 126
2022
Q3
$107M Buy
467,347
+9,430
+2% +$2.29M 0.13% 129
2022
Q2
$111M Sell
457,917
-68,374
-13% -$16.8M 0.13% 138
2022
Q1
$127M Buy
526,291
+5,737
+1% +$1.32M 0.12% 146
2021
Q4
$117M Sell
520,554
-10,384
-2% -$2.19M 0.1% 173
2021
Q3
$113M Sell
530,938
-2,657
-0.5% -$612K 0.12% 135
2021
Q2
$129M Sell
533,595
-16,538
-3% -$4.07M 0.13% 134
2021
Q1
$137M Buy
550,133
+38,077
+7% +$9.09M 0.15% 117
2020
Q4
$118M Buy
512,056
+49,584
+11% +$11.4M 0.14% 131
2020
Q3
$118M Buy
462,472
+83,340
+22% +$20.6M 0.16% 125
2020
Q2
$89.4M Sell
379,132
-67,148
-15% -$15.3M 0.13% 140
2020
Q1
$90.5M Sell
446,280
-5,271
-1% -$1.15M 0.15% 128
2019
Q4
$109M Sell
451,551
-6,569
-1% -$1.45M 0.16% 129
2019
Q3
$88.7M Buy
458,120
+68,020
+17% +$13.1M 0.14% 141
2019
Q2
$71.9M Buy
390,100
+40,310
+12% +$7.22M 0.11% 156
2019
Q1
$66.5M Sell
349,790
-295,990
-46% -$56.5M 0.1% 166
2018
Q4
$126M Buy
645,780
+32,943
+5% +$6.43M 0.22% 89
2018
Q3
$127M Sell
612,837
-46,959
-7% -$9.25M 0.19% 97
2018
Q2
$122M Buy
659,796
+114,125
+21% +$20.2M 0.19% 103
2018
Q1
$93M Buy
545,671
+1,357
+0.2% +$249K 0.14% 132
2017
Q4
$94.7M Sell
544,314
-7,384
-1% -$1.31M 0.14% 128
2017
Q3
$103M Sell
551,698
-18,298
-3% -$3.24M 0.15% 117
2017
Q2
$98.2M Sell
569,996
-2,153
-0.4% -$350K 0.15% 115
2017
Q1
$93.9M Buy
572,149
+37,202
+7% +$6.18M 0.15% 122
2016
Q4
$78.2M Buy
534,947
+102,688
+24% +$15.5M 0.13% 134
2016
Q3
$72.1M Buy
432,259
+5,277
+1% +$892K 0.12% 146
2016
Q2
$65M Buy
426,982
+6,542
+2% +$1.02M 0.12% 155
2016
Q1
$63M Sell
420,440
-21,672
-5% -$3.22M 0.12% 140
2015
Q4
$71.8M Sell
442,112
-3,976
-0.9% -$625K 0.14% 129
2015
Q3
$61.7M Sell
446,088
-25,755
-5% -$4.06M 0.12% 142
2015
Q2
$72.4M Buy
471,843
+11,164
+2% +$1.79M 0.13% 135
2015
Q1
$73.6M Sell
460,679
-51,429
-10% -$8.1M 0.13% 136
2014
Q4
$81.6M Buy
512,108
+45,908
+10% +$7.15M 0.14% 133
2014
Q3
$65.5M Sell
466,200
-3,077
-0.7% -$402K 0.11% 144
2014
Q2
$55.5M Sell
469,277
-35,625
-7% -$4.12M 0.09% 165
2014
Q1
$62.3M Sell
504,902
-9,575
-2% -$1.16M 0.11% 147
2013
Q4
$58.7M Sell
514,477
-78,134
-13% -$8.89M 0.11% 148
2013
Q3
$66.3M Buy
592,611
+36,200
+7% +$3.93M 0.13% 132
2013
Q2
$54.9M Buy
+556,411
New +$57.7M 0.12% 140

Other funds holding AMGN

TD Asset Management's AMGN Position: Q1 2026 in Review

TD Asset Management increased its Amgen (AMGN) stake by 10% in Q1 2026, buying an estimated $13.3M and bringing the position to 404,449 shares worth $142M. The position accounts for 0.12% of the portfolio, ranked #156.

TD Asset Management first reported a position in AMGN in Q2 2013 and has held it in 52 quarters since. The position peaked at $183M in Q2 2024. 3,129 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.

  • TD Asset Management held 404,449 shares of Amgen worth $142M as of Q1 2026.
  • TD Asset Management bought 37,202 Amgen shares in Q1 2026, an estimated $13.3M.
  • Amgen made up 0.12% of TD Asset Management's portfolio in Q1 2026, its #156 holding.
  • TD Asset Management first reported a position in Amgen in Q2 2013 and has held it in 52 quarters since.
  • TD Asset Management's Amgen position peaked at $183M in Q2 2024.
  • 3,129 funds tracked by Wall St. Rank held Amgen as of Q1 2026.

Based on TD Asset Management's 13F filing for Q1 2026, filed 11 May 2026.